Understanding why your body may respond differently to GLP-1 therapy requires more than symptom observationit benefits from biomarker context and genetic predisposition screening
Asia-Pacific is expected to be the fastest-growing region at a CAGR of 9.4% from 2026 to 2033, fueled by the rapidly increasing diabetic population, expanding healthcare infrastructure, rising healthcare expenditure, and improving access to advanced biologic therapies across China, India, Japan, and South Korea
Monitoring trends Small weight fluctuations are normal
This analysis further assessed whether the increase in DRP was a GLP-1 specific effect, or rather caused by a robust and early glucose lowering as suggested by several other studies, where acute and large reductions in glucose concentrations may initially and transiently worsen DRP, yet prevent or delay onset or progression of DRP in the long term (123128)
The Reset's meals and snacks are packed with whole, natural ingredients
Both also spent more time in the empty chamber, indicating social aversion